87 related articles for article (PubMed ID: 30176247)
1. MG-132 treatment promotes TRAIL-mediated apoptosis in SEB-1 sebocytes.
Ji J; Zhou BR; Zhang RH; Li HM; Guo Q; Zhu J; Luo D
Life Sci; 2018 Oct; 210():150-157. PubMed ID: 30176247
[TBL] [Abstract][Full Text] [Related]
2. TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells.
Nelson AM; Cong Z; Gilliland KL; Thiboutot DM
Br J Dermatol; 2011 Sep; 165(3):526-33. PubMed ID: 21564055
[TBL] [Abstract][Full Text] [Related]
3. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
[TBL] [Abstract][Full Text] [Related]
4. 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes.
Nelson AM; Gilliland KL; Cong Z; Thiboutot DM
J Invest Dermatol; 2006 Oct; 126(10):2178-89. PubMed ID: 16575387
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis.
Saulle E; Petronelli A; Pasquini L; Petrucci E; Mariani G; Biffoni M; Ferretti G; Scambia G; Benedetti-Panici P; Cognetti F; Humphreys R; Peschle C; Testa U
Apoptosis; 2007 Apr; 12(4):635-55. PubMed ID: 17252198
[TBL] [Abstract][Full Text] [Related]
6. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
Chaturvedi V; Bodner B; Qin JZ; Nickoloff BJ
J Dermatol Sci; 2006 Jan; 41(1):31-41. PubMed ID: 16289694
[TBL] [Abstract][Full Text] [Related]
7. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
[TBL] [Abstract][Full Text] [Related]
8. The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells.
Kabore AF; Sun J; Hu X; McCrea K; Johnston JB; Gibson SB
Apoptosis; 2006 Jul; 11(7):1175-93. PubMed ID: 16699949
[TBL] [Abstract][Full Text] [Related]
9. Trifloxystrobin induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in HaCaT, human keratinocyte cells.
Jang Y; Lee AY; Chang SH; Jeong SH; Park KH; Paik MK; Cho NJ; Kim JE; Cho MH
Drug Chem Toxicol; 2017 Jan; 40(1):67-73. PubMed ID: 27149887
[TBL] [Abstract][Full Text] [Related]
10. Insulin promotes vascular smooth muscle cell proliferation and apoptosis via differential regulation of tumor necrosis factor-related apoptosis-inducing ligand.
Harith HH; Di Bartolo BA; Cartland SP; Genner S; Kavurma MM
J Diabetes; 2016 Jul; 8(4):568-78. PubMed ID: 26333348
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS
Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitor MG132 potentiates TRAIL-induced apoptosis in gallbladder carcinoma GBC-SD cells via DR5-dependent pathway.
Zhu W; Zhan D; Wang L; Ma D; Cheng M; Wang H; Zhao J; Cai Y; Cheng Z
Oncol Rep; 2016 Aug; 36(2):845-52. PubMed ID: 27277541
[TBL] [Abstract][Full Text] [Related]
14. Low-dose UV-radiation sensitizes keratinocytes to TRAIL-induced apoptosis.
Qin JZ; Bacon P; Panella J; Sitailo LA; Denning MF; Nickoloff BJ
J Cell Physiol; 2004 Jul; 200(1):155-66. PubMed ID: 15137068
[TBL] [Abstract][Full Text] [Related]
15. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim.
Xia S; Li Y; Rosen EM; Laterra J
Mol Cancer Res; 2007 Aug; 5(8):783-92. PubMed ID: 17699104
[TBL] [Abstract][Full Text] [Related]
16. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1).
Thiboutot D; Jabara S; McAllister JM; Sivarajah A; Gilliland K; Cong Z; Clawson G
J Invest Dermatol; 2003 Jun; 120(6):905-14. PubMed ID: 12787114
[TBL] [Abstract][Full Text] [Related]
17. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.
Leverkus M; Neumann M; Mengling T; Rauch CT; Bröcker EB; Krammer PH; Walczak H
Cancer Res; 2000 Feb; 60(3):553-9. PubMed ID: 10676636
[TBL] [Abstract][Full Text] [Related]
19. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
[TBL] [Abstract][Full Text] [Related]
20. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
Shankar S; Singh TR; Srivastava RK
Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
